SMTL ID : 5ni5.1

Ligand complex of RORg LBD

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

hetero-1-1-mer

Ligands

1 x 8YB: ~{N}-[4-(3-chlorophenyl)-5-(2-chlorophenyl)carbonyl-1,3-thiazol-2-yl]-2-(4-ethylsulfonylphenyl)ethanamide(Non-covalent)

8YB.1: 19 residues within 4Å: Chain A: C.43, Q.44, L.45, L.50, C.78, H.81, L.82, M.116, R.122, M.123, R.125, A.126, V.134, F.135, F.136, F.146, I.158, F.159, S.162 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:Q.44, A:L.45, A:L.82, A:R.122, A:A.126, A:V.134, A:F.146, A:I.158, A:I.158, A:F.159 Hydrogen bonds: A:F.135 Water bridges: A:E.137 pi-Stacking: A:F.136 Halogen bonds: A:S.162

1 x NA: SODIUM ION(Non-functional Binders)

NA.2: 4 residues within 4Å: Chain A: R.54, C.124, Y.127, S.166 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.54, A:C.124 Water bridges: A:A.129

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Narjes, F. et al., Potent and Orally Bioavailable Inverse Agonists of ROR gamma t Resulting from Structure-Based Design. J. Med. Chem. (2018)

Release Date

2018-08-22

Peptides

Nuclear receptor ROR-gamma: A
tethered SRC2-2 peptide: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

Nuclear receptor ROR-gamma

tethered SRC2-2 peptide

Related Entries With Identical Sequence